日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of the SARS-CoV-2 Papain-Like Protease Inhibitor MR1-114: From Structure-Based Design to In Vivo Antiviral Efficacy

SARS-CoV-2木瓜蛋白酶样蛋白酶抑制剂MR1-114的发现:从基于结构的药物设计到体内抗病毒功效

Gannarapu, Malla Reddy; Indukuri, Divakar; Holberg, Cameron; Ratia, Kiira; Ramos, Omar Lozano; Cardoza, Savio; Velma, Ganga Reddy; Musku, Soumya Reddy; Qi, Zuohuang; Slilaty, Steve; Li, Zuomei; Rong, Lijun; Thatcher, Gregory R J; Xiong, Rui

Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications

2025年获FDA批准的含氮药物:合成、意义和治疗应用

Jadala, Chetna; Mishra, Shweta; Potuganti, Gal Reddy; Cardoza, Savio; Velma, Ganga Reddy

Fluorine-containing FDA-approved small-molecule drugs in 2025: significance, synthetic insights, and therapeutic applications

2025年FDA批准的含氟小分子药物:意义、合成见解和治疗应用

Mishra, Shweta; Jadala, Chetna; Cardoza, Savio; Potuganti, Gal Reddy; Velma, Ganga Reddy

Development of a high-throughput TR-FRET assay to identify inhibitors of the FAK-paxillin protein-protein interaction.

开发高通量 TR-FRET 检测方法,以鉴定 FAK-paxillin 蛋白-蛋白相互作用的抑制剂

Aromokeye Rukayat, Ackerman-Berrier Martha, Araujo Rosa Del Carmen, Lambousis Maria, Cardoza Savio, Chen L Charlie, Kaplan Matthew E, Zhu Haining, Penton Christopher, Zerbinatti Celina, Thatcher Gregory R J, Marlowe Timothy

Synthesis of C3,C6-Diaryl 7-Azaindoles via One-Pot Suzuki-Miyaura Cross-Coupling Reaction and Evaluation of Their HIV-1 Integrase Inhibitory Activity.

通过一锅法 Suzuki-Miyaura 交叉偶联反应合成 C3,C6-二芳基 7-氮杂吲哚并评价其 HIV-1 整合酶抑制活性

Cardoza Savio, Yadav Pooja, Ajmani Abhishek, Das Parthasarathi, Tandon Vibha